ID   iPD-C2
AC   CVCL_A4MR
DR   SKIP; SKIP003177
DR   Wikidata; Q105509687
RX   PubMed=29513666;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; chr12:g.40197315A>G; dbSNP=rs1491923; Zygosity=Unspecified (PubMed=29513666).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=29513666; DOI=10.1371/journal.pone.0192497; PMCID=PMC5841660;
RA   Marrone L., Bus C., Schondorf D.C., Fitzgerald J.C., Kubler M.,
RA   Schmid B., Reinhardt P., Reinhardt L., Deleidi M., Levin T.,
RA   Meixner A., Klink B., Glatza M., Gloeckner C.J., Gasser T.,
RA   Sterneckert J.;
RT   "Generation of iPSCs carrying a common LRRK2 risk allele for in vitro
RT   modeling of idiopathic Parkinson's disease.";
RL   PLoS ONE 13:E0192497-E0192497(2018).
//